Navigation Links
Global Biomarkers Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Date:10/20/2013

Albany, New York, USA (PRWEB) October 20, 2013

A biomarker is a gene, molecule or characteristics, by which pathogenic processes, biological processes or pharmacologic response can be evaluated or measured. They are classified on the basis of their application in different medical processes. These biomarkers help effectively in clinical decision making and thus help in diagnosing the health of a patient. In the present scenario, biomarkers are extensively used in the treatment of diseases such as cancer.

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/biomarkers-market.html.

The worldwide market of biomarkers is increasing tremendously due to its popularity and wide use in different drug discovery. Its extensive use in medical areas such as research and cancer treatment is highly increasing its demand. Several new companies are entering the biomarker market and new acquisitions and mergers are further supporting the growth of this market.

The global biomarker market was worth USD 13.16 in 2011 and it is expected to reach USD 34 billion by 2018, growing at a CAGR of 14.70% from 2011 to 2018. As of now, oncology earned the highest revenue but cardiology is expected to grow at a faster rate at a CAGR of 16.32% from 2011 to 2018. North America is noticed as the fastest growing region due to high adoption rate of high throughput technologies used in biomarker discovery, wide use of biomarkers in cancer treatment and rapid growth of IT industry in that region.

The new product launches, emergence of new players in the market and several mergers, acquisitions and joint ventures serve as a major driver for the growth of the biomarkers market. Major players in the biomarkers market are Abbott Laboratories, Agilent Technologies Inc., Affymetrix Inc., Becton, Dickinson and Company, Celera Corporation, Bruker Corporation,DiagnoCure Inc., Epigenomics AG, Clarient Inc., and GE Healthcare among others.

Related Report : Cancer Biomarkers Market
http://www.transparencymarketresearch.com/cancer-biomarkers-market.html

Reasons for Buying this Report

-This report provides pin-point analysis for changing competitive dynamics
-It provides a forward looking perspective on different factors driving or restraining market growth
-It provides a technological growth map over time to understand the industry growth rate
-It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
-It helps in understanding the key product segments and their future
-It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
-It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
-It provides distinctive graphics and exemplified SWOT analysis of major market segments

Browse Blog: http://udallas.academia.edu/transparencymarketresearch/
Browse all Market Research reports: http://www.transparencymarketresearch.com

Read the full story at http://www.prweb.com/releases/2013/10/prweb11246531.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Cardiac Prosthetic Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
2. It Works! Global Restocks the Shelves of the Salvation Army
3. Texas A&M Advances Global Disease Prevention with Launch of Field-to-Clinic Initiative
4. República’s Jorge A. Plasencia and Luis Casamayor Recognized as Global Agency Innovators by The Internationalist Magazine
5. LDM Global eDiscovery Professional, Jennifer Holt, is Awarded CEDS Certification
6. RAPS Releases New Edition of Unique Global Regulatory Affairs Reference Book
7. Global Breast Pumps Industry – New Research Available
8. Global Metal Packaging Industry
9. Vitamin D3 Market in China and Global Regions 2013 Structure and Value Analysis in a New Research Study at DeepResearchReports.com
10. Operation Smile’s 2013 Smile Gala and Global Summit Celebrates 30 Years of Successes
11. Global Medical Imaging Reagents Market 2016 Forecast Report Now Available at ReportsnReports.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: